entity

NRG1/ERBB4

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NRG1/ERBB4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
1Hypotheses
1Analyses
4Outgoing
1Incoming
0Experiments
1Debates

Wiki Pages (4)

Knowledge base pages for this entity

PD EGFR and Receptor Tyrosine Kinase Therapeutic Companies

company · 1817 words

Cell Migration

biological_process · 1785 words

NRG1 Protein

protein · 738 words

NRG1 Gene

gene · 685 words

Outgoing (4)

TargetRelationTypeStr
neurodegenerationassociated_withdisease0.40
neurodegenerationimplicated_indisease0.40
BACE1co_associated_withgene0.30
NRG1co_associated_withgene0.30

Incoming (1)

SourceRelationTypeStr
h-73124693targetshypothesis0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
BACE1/NRG1 Axis Dysfunction Drives Excitatory/Inhibitory Imb 0.599 neurodegeneration What are the physiological functions of

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.599

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract identifies BACE1 as an attractive drug target but doesn't address i

active · Rounds: 4 · Score: 0.75 · 2026-04-16